{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:37:35Z","timestamp":1773311855153,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T00:00:00Z","timestamp":1249948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold><jats:bold>Background:\u2002<\/jats:bold>The HLA\u2010B8, DR3 haplotype has been associated with high immune reactivity. In this study, we have tested whether this haplotype has differential effect on graft survival in patients with IgAN compared with control patients.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>From the Eurotransplant Registry we analyzed graft survival of 1207 recipients with IgAN and 7935 control patients with non\u2010glomerular diseases. Death\u2010censored graft loss according to the HLA\u2010B8, DR3 haplotype was calculated with Kaplan\u2013Meier analysis and Cox\u2010regression model was used to correct for various risk factors.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>The frequency of the HLA\u2010B8, DR3 haplotype was significantly lower in IgAN patients compared with controls (10.3% vs. 15.4%, p\u2003&lt;\u20030.001). Ten\u2010year graft survival was identical in the control group with and without the HLA\u2010B8, DR3 haplotype (71.1% and 70.2%, respectively), but significantly worse in IgAN patients carrying the HLA\u2010B8, DR3 haplotype compared with patients without it (52.5% vs. 69.1%, respectively, p\u2003=\u20030.009). The risk of graft loss was increased by 66% (HR 1.6, 95% CI 1.14, 2.29) in IgAN with the HLA\u2010B8, DR3 haplotype and independent of well\u2010known risk factors.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>We have identified a new risk factor for graft loss unique to patients with IgAN. This finding emphasizes the exclusive immune characteristics of IgAN patients after transplantation.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2009.01059.x","type":"journal-article","created":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T17:41:36Z","timestamp":1250012496000},"page":"660-665","source":"Crossref","is-referenced-by-count":19,"title":["HLA\u2010B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy"],"prefix":"10.1111","volume":"23","author":[{"given":"Margret B.","family":"Andresdottir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert W.","family":"Haasnoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido G.","family":"Persijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans H.J.","family":"Claas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1276"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01398.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(03)00079-9"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)02102-3"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200004150-00047"},{"key":"e_1_2_6_7_2","first-page":"279","article-title":"Favorable outcome of renal transplantation in patients with IgA nephropathy","volume":"56","author":"Andresdottir MB","year":"2001","journal-title":"Clin Nephrol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000179150.84803.56"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1399-0012.1992.tb00599.x","article-title":"High survival rate of kidney transplants in IgA nephropathy patients","volume":"6","author":"Lim ECTP","year":"1992","journal-title":"Clin Transplant"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2001.057004344.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/08916939809003866"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.2.557"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(01)00264-6"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198101223040401"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1996.16.983"},{"key":"e_1_2_6_16_2","first-page":"72","article-title":"Blood antiphospholipid antibody levels are influenced by age, sex and HLA\u2010B8,DR3 phenotype","volume":"9","author":"Colucci AT","year":"1992","journal-title":"Exp Clin Immunogenet"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2000.0779"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00536.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200108270-00017"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.03.091"},{"key":"e_1_2_6_21_2","first-page":"308","article-title":"HLA\u2010DR3 associated with improved kidney transplant survival","volume":"14","author":"Cicciarelli JC","year":"1982","journal-title":"Transplant Proc"},{"key":"e_1_2_6_22_2","first-page":"2408","article-title":"Beneficial effects of HLA\u2010DR3 gene expression on renal allograft survival in black recipients","volume":"25","author":"Ross W","year":"1993","journal-title":"Transplant Proc"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1399-0012.1996.tb00646.x","article-title":"Effect of HLA\u2010DR3 gene expression on cadaveric renal allograft survival in blacks","volume":"10","author":"Ngcobo TK","year":"1996","journal-title":"Clin Transplant"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-3274(99)80038-0"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2009.01059.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2009.01059.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:30:33Z","timestamp":1739298633000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2009.01059.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1399-0012.2009.01059.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2009.01059.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}